From: Proceedings of Réanimation 2018, the French Intensive Care Society International Congress
Group | p value | ||
---|---|---|---|
Placebo (n = 45) | Remifentanil (n = 45) | ||
Maximal VNRPS | 50 (40–60) | 20 (16–40) | .0009* |
VNRPS at punction | 30 (20–30) | 20 (2–20) | .0746 |
VNRPS at dilatation | 40 (25–40) | 10 (0–20) | .0005* |
VNRPS at fixation | 30 (20–40) | 10 (0–20) | .0153* |
N. of punctions | 1 (1–2) | 1 (1–1) | .3446 |
Duration (mn) | 17 (14–22) | 15 (14–19) | .3389 |
Dose (µg/kg/mn) | 0 (NA) | 0.135 (0.12–0.15) | NA |
Total dose (µg) | 0 (NA) | 136 (120–164.6) | NA |